Cargando…
Why can primary angioplastics be ineffective despite the precocity of the intervention?
Early coronary revascularization is a first choice therapeutic strategy in the case of acute myocardial infarction (MI). Despite an early coronary angioplasty, however, in some cases, there is a lower efficacy of revascularization, with less favourable clinical outcome in the short and long terms. V...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653124/ https://www.ncbi.nlm.nih.gov/pubmed/36380792 http://dx.doi.org/10.1093/eurheartjsupp/suac102 |
_version_ | 1784828617943941120 |
---|---|
author | Patti, Giuseppe Ghiglieno, Chiara |
author_facet | Patti, Giuseppe Ghiglieno, Chiara |
author_sort | Patti, Giuseppe |
collection | PubMed |
description | Early coronary revascularization is a first choice therapeutic strategy in the case of acute myocardial infarction (MI). Despite an early coronary angioplasty, however, in some cases, there is a lower efficacy of revascularization, with less favourable clinical outcome in the short and long terms. Various elements participate in the distant prognosis after primary coronary angioplasty (PCI). Among the clinical risk factors that predispose to a recurrence of ischaemic cardiovascular events are advanced age, diabetes mellitus, chronic renal failure, peripheral vascular disease, atrial fibrillation and the multiplicity of cardiovascular risk factors, which identify a higher baseline risk profile. The risk factors associated with the percutaneous interventional procedure include the presence of diffuse or complex coronary lesions, the use of small diameter stents or a suboptimal post procedural thrombolysis in MI flow. The occurrence of procedural complications, such as no-reflow, is in fact associated with an increase in the infarct area and a worse prognosis, as it favours negative ventricular remodelling. The presence of concomitant right ventricular dysfunction, the high ventricular arrhythmic burden in the acute phase, the presence of risk factors for thrombosis or intra-stent restenosis also affect the outcome after primary PCI. |
format | Online Article Text |
id | pubmed-9653124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96531242022-11-14 Why can primary angioplastics be ineffective despite the precocity of the intervention? Patti, Giuseppe Ghiglieno, Chiara Eur Heart J Suppl CCC 2022 - State of the Art Cardiology Supplement Paper Early coronary revascularization is a first choice therapeutic strategy in the case of acute myocardial infarction (MI). Despite an early coronary angioplasty, however, in some cases, there is a lower efficacy of revascularization, with less favourable clinical outcome in the short and long terms. Various elements participate in the distant prognosis after primary coronary angioplasty (PCI). Among the clinical risk factors that predispose to a recurrence of ischaemic cardiovascular events are advanced age, diabetes mellitus, chronic renal failure, peripheral vascular disease, atrial fibrillation and the multiplicity of cardiovascular risk factors, which identify a higher baseline risk profile. The risk factors associated with the percutaneous interventional procedure include the presence of diffuse or complex coronary lesions, the use of small diameter stents or a suboptimal post procedural thrombolysis in MI flow. The occurrence of procedural complications, such as no-reflow, is in fact associated with an increase in the infarct area and a worse prognosis, as it favours negative ventricular remodelling. The presence of concomitant right ventricular dysfunction, the high ventricular arrhythmic burden in the acute phase, the presence of risk factors for thrombosis or intra-stent restenosis also affect the outcome after primary PCI. Oxford University Press 2022-11-12 /pmc/articles/PMC9653124/ /pubmed/36380792 http://dx.doi.org/10.1093/eurheartjsupp/suac102 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | CCC 2022 - State of the Art Cardiology Supplement Paper Patti, Giuseppe Ghiglieno, Chiara Why can primary angioplastics be ineffective despite the precocity of the intervention? |
title | Why can primary angioplastics be ineffective despite the precocity of the intervention? |
title_full | Why can primary angioplastics be ineffective despite the precocity of the intervention? |
title_fullStr | Why can primary angioplastics be ineffective despite the precocity of the intervention? |
title_full_unstemmed | Why can primary angioplastics be ineffective despite the precocity of the intervention? |
title_short | Why can primary angioplastics be ineffective despite the precocity of the intervention? |
title_sort | why can primary angioplastics be ineffective despite the precocity of the intervention? |
topic | CCC 2022 - State of the Art Cardiology Supplement Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653124/ https://www.ncbi.nlm.nih.gov/pubmed/36380792 http://dx.doi.org/10.1093/eurheartjsupp/suac102 |
work_keys_str_mv | AT pattigiuseppe whycanprimaryangioplasticsbeineffectivedespitetheprecocityoftheintervention AT ghiglienochiara whycanprimaryangioplasticsbeineffectivedespitetheprecocityoftheintervention |